Wikipedia

Chen Lan-bo

(Redirected from Lan-Bo Chen)

Chen Lan-bo (Chinese: 陳良博) is a Taiwanese biotechnologist. He was a professor of pathology at Harvard Medical School between 1977 and 2004 and is the author of over 250 publications. He is also a member of Boston's Dana-Farber Cancer Institute[1] in the department of cancer and biology and a member of the Academia Sinica of Taiwan.

Lan Bo Chen
陳良博
Alma mater
Awards
Scientific career
Institutions
Website

Early life and education

edit

Chen was born on 23 August 1943 in Yilan, Taiwan. He received his B.S. in chemistry from National Taiwan University in Taiwan, followed by his Ph.D. in cell biology at the Massachusetts Institute of technology.[2][3]

Research and career

edit

Chen did postdoctoral research work for one year supervised by James D. Watson, the Nobel laureate who co-discovered the DNA double helix structure.[4] He did research on the mitogenicity of thrombin and surface alterations on mouse splenocytes and also on intercellular LETS glycoprotein matrices.[5]

He is also a cell biologist making seminal findings in the multiple fields of molecular cell biology and cancer biology, including the discovery of rhodamine 123 for highly specific fluorescent localization of mitochondria in living cells, removal of carcinoma cells from contaminated bone marrow using the lipophilic cation, identification of human cancer line without any Intermediate filaments, and also on the development of the rare event detection system to detect lung cancer cells from Body fluids.[6][7][8]

In the early days of his career, he worked as a Senior Staff investigator at the Cold Spring Harbor Laboratories, before becoming a full and emeritus professor of pathology at the Harvard Medical School with laboratories at the Dana-Farber Cancer Institute.

Chen founded Synta Pharmaceuticals Corporation,[9][10] and in 2007, was invited to serve on the founding board of directors for Yu Chang Biologics Company, also known as TaiMed Biologics Company.[11][12] Chen was supportive of Tsai Ing-wen's 2012 presidential campaign after Tsai's involvement with TaiMed became a subject of investigation.[13][14] Chen described the Sunflower Student Movement of 2014 as "the mightiest movement Taiwan has seen in several decades" and said that "this student movement will kick-start the development of Taiwan’s biotech industry."[15] In January 2019, Chen signed a petition opposing the confirmation of Kuan Chung-ming as president of National Taiwan University.[16]

Awards and honors

edit

Chen received the American Cancer Society Professor award,[17] and, in 1996, was elected as a member of the Academia Sinica.[18] He also served as a former board member at Madrigal Pharmaceuticals.[19]

Publications

edit

Chen has published over 250 publications.[20] His contributions include the following:

  • Lan Bo Chen. "Mitochondrial Membrane Potential in Living Cells". Annual Review of Cell Biology.[21]
  • Lan Bo Chen, Andrew Murray, Rosalind A. Segal, Anne Bushnell, and Marcia L. Walsh. "Studies on intercellular LETS glycoprotein matrices". Journal of the cell.[22]
  • L B Chen, P H Gallimore, and J K McDougall. "Correlation between tumor induction and the large external transformation sensitive protein on the cell surface". Journal of PNAS.[23]
  • Lan Bo Chen. "Fluorescent Labeling of Mitochondria". Methods in cell biology.[24]
  • L.B.Chen, N.Maitland, P.H.Gallimore, and J.K.McDougall. "Detection of the large external transformation-sensitive protein on some epithelial cells". Journal of Experimental cell research.[25]
  • L.B.Chen, N.N.H.Teng, and J.M.Buchanan. "Mitogenicity of thrombin and surface alterations on mouse splenocytes". Journal of Experimental cell research.[26]
  • Lan Bo Chen and John M. Buchanan. "Plasminogen-Independent Fibrinolysis by Proteases Produced by Transformed Chick Embryo Fibroblasts". JSTOR.[27]
  • Lan Bo Chen, Keith Burridge, Andrew Murray, Marcia L. Walsh, Christine D. Copple, Anne Bushnell, James K. McDougall, and Phillip H. Gallimore. "Modulation of Cell Surface Glycocalyx: Studies on Large, External, Transformation-Sensitive Protein". Annals of the New York Academy of Sciences.[28]
  • Faith E. Davies, Ann M. Dring, Cheng Li, Andrew C. Rawstron, Masood A. Shammas, Sheila M. O'Connor, James A.L. Fenton, Teru Hideshima, Dharminder Chauhan, Isabella T. Tai, Elizabeth Robinson, Daniel Auclair, Karen Rees, David Gonzalez, A. John Ashcroft, Ranjit Dasgupta, Constantine Mitsiades, Nicholas Mitsiades, Lan B. Chen, Wing H. Wong, Nikhil C. Munshi, Gareth J. Morgan, and Kenneth C. Anderson. "Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis". Blood Journal.[29]
  • Xiuwei Yang, Christoph Claas, Stine-Kathrein Kraeft, Lan Bo Chen, Zemin Wang, Jordan A. Kreidberg, and Martin E. Hemler. "Palmitoylation of Tetraspanin Proteins: Modulation of CD151 Lateral Interactions, Subcellular Distribution, and Integrin-dependent Cell Morphology". Molecular Biology of the cell.[30]

References

edit
  1. ^ www.bizjournals.com https://www.bizjournals.com/boston/stories/2002/11/11/story5.html. Retrieved 2020-01-20. {{cite web}}: Missing or empty |title= (help)
  2. ^ "Dr. Lan Bo Chen | Delos Capital". Retrieved 2020-01-20.
  3. ^ "Lan-Bo Chen, CHO Pharma Inc: Profile and Biography - Bloomberg Markets". Bloomberg.com. Retrieved 2020-01-20.
  4. ^ "Delos Capital Announces the Launch of Curamir Therapeutics Inc. with a $10 Million Series A to Develop miRNA-based Cancer Therapeutics". BioSpace. Retrieved 2020-01-20.
  5. ^ Chen, L. B.; Teng, N. N. H.; Buchanan, J. M. (1976-08-01). "Mitogenicity of thrombin and surface alterations on mouse splenocytes". Experimental Cell Research. 101 (1): 41–46. doi:10.1016/0014-4827(76)90409-2. ISSN 0014-4827. PMID 986310.
  6. ^ Lampidis, Theodore J.; Salet, Christian; Moreno, Giuliana; Chen, Lan Bo (1984-09-01). "Effects of the mitochondrial probe rhodamine 123 and related analogs on the function and viability of pulsating myocardial cells in culture". Agents and Actions. 14 (5): 751–757. doi:10.1007/BF01978920. ISSN 1420-908X. PMID 6475672. S2CID 1341638.
  7. ^ Johnson, Lincoln V.; Summerhayes, Ian C.; Chen, Lan Bo (1982-01-01). "Decreased uptake and retention of rhodamine 123 by mitochondria in feline sarcoma virus-transformed mink cells". Cell. 28 (1): 7–14. doi:10.1016/0092-8674(82)90369-5. ISSN 0092-8674. PMID 6279315. S2CID 38032526.
  8. ^ Lampidis, T. J.; Bernal, S. D.; Summerhayes, I. C.; Chen, L. B. (February 1983). "Selective toxicity of rhodamine 123 in carcinoma cells in vitro". Cancer Research. 43 (2): 716–720. ISSN 0008-5472. PMID 6848187.
  9. ^ Willis, Randall C. (September 2004). "Bad news for Beantown?". ACS Publications. Retrieved 1 January 2019.
  10. ^ Connolly, Allison (11 November 2002). "$45M in private financing vaults Synta's profile". Boston Business Journal. Retrieved 2 January 2019.
  11. ^ "New AIDS research firm to be created". Taipei Times. 14 September 2007. Retrieved 1 January 2019.
  12. ^ Kao, Cameron (8 July 2014). "Biomedical industry gets a clean bill of health: expert". Taipei Times. Retrieved 1 January 2019.
  13. ^ Chang, Rich (15 August 2012). "Tsai cleared of Yu Chang allegations". Taipei Times. Retrieved 1 January 2019.
  14. ^ Wang, Chris (16 December 2011). "2012 ELECTIONS: Key figures speak out to support Tsai". Taipei Times. Retrieved 1 January 2019.
  15. ^ Huang, Tien-lien (10 July 2014). "Sunflower movement helped lift economy". Taipei Times. Retrieved 1 January 2019.
  16. ^ Maxon, Ann (2 January 2019). "Academics ask ministry to annul Kuan appointment". Taipei Times. Retrieved 2 January 2019.
  17. ^ "sinica.edu". sinica.edu.tw.
  18. ^ "Lan-Bo Chen". Academia Sinica. Retrieved 8 September 2023.
  19. ^ "Dr. Lan Bo Chen Ph.D.- Executive Bio, Work History, and Contacts - Equilar BoardEdge". people.equilar.com. Retrieved 2020-01-20.
  20. ^ "Lan Bo Chen - Google Scholar Citations". scholar.google.com. Retrieved 2019-12-12.
  21. ^ Chen, Lan Bo (1988-11-01). "Mitochondrial Membrane Potential in Living Cells". Annual Review of Cell Biology. 4 (1): 155–181. doi:10.1146/annurev.cb.04.110188.001103. ISSN 0743-4634. PMID 3058159.
  22. ^ Chen, Lan Bo; Murray, Andrew; Segal, Rosalind A.; Bushnell, Anne; Walsh, Marcia L. (1978-06-01). "Studies on intercellular LETS glycoprotein matrices". Cell. 14 (2): 377–391. doi:10.1016/0092-8674(78)90123-X. ISSN 0092-8674. PMID 667946. S2CID 21963330.
  23. ^ Chen, L. B.; Gallimore, P. H.; McDougall, J. K. (1976-10-01). "Correlation between tumor induction and the large external transformation sensitive protein on the cell surface". Proceedings of the National Academy of Sciences. 73 (10): 3570–3574. Bibcode:1976PNAS...73.3570C. doi:10.1073/pnas.73.10.3570. ISSN 0027-8424. PMC 431159. PMID 1068469.
  24. ^ Chen, Lan Bo (1988-01-01). "Chapter 7 Fluorescent Labeling of Mitochondria". In Wang, Yu-Li; Taylor, D. Lansing; Jeon, K. W. (eds.). Fluorescence Microscopy of Living Cells in Culture Part A . Fluorescent Analogs, Labeling Cells, and Basic Microscopy. Methods in Cell Biology. Vol. 29. Academic Press. pp. 103–123. doi:10.1016/s0091-679x(08)60190-9. ISBN 9780125641296. PMID 2643756. Retrieved 2019-12-12.
  25. ^ Chen, L. B.; Maitland, N.; Gallimore, P. H.; McDougall, J. K. (1977-04-01). "Detection of the large external transformation-sensitive protein on some epithelial cells". Experimental Cell Research. 106 (1): 39–46. doi:10.1016/0014-4827(77)90238-5. ISSN 0014-4827. PMID 852517.
  26. ^ Chen, L. B.; Teng, N. N. H.; Buchanan, J. M. (1976-08-01). "Mitogenicity of thrombin and surface alterations on mouse splenocytes". Experimental Cell Research. 101 (1): 41–46. doi:10.1016/0014-4827(76)90409-2. ISSN 0014-4827. PMID 986310.
  27. ^ Chen, Lan Bo; Buchanan, John M. (1975). "Plasminogen-Independent Fibrinolysis by Proteases Produced by Transformed Chick Embryo Fibroblasts". Proceedings of the National Academy of Sciences of the United States of America. 72 (3): 1132–1136. Bibcode:1975PNAS...72.1132C. doi:10.1073/pnas.72.3.1132. ISSN 0027-8424. JSTOR 64433. PMC 432480. PMID 165484.
  28. ^ Chen, Lan Bo; Burridge, Keith; Murray, Andrew; Walsh, Marcia L.; Copple, Christine D.; Bushnell, Anne; McDougall, James K.; Gallimore, Phillip H. (1978). "Modulation of Cell Surface Glycocalyx: Studies on Large, External, Transformation-Sensitive Protein*". Annals of the New York Academy of Sciences. 312 (1): 366–381. Bibcode:1978NYASA.312..366C. doi:10.1111/j.1749-6632.1978.tb16814.x. ISSN 1749-6632. PMID 386883. S2CID 32711763.
  29. ^ Davies, Faith E.; Dring, Ann M.; Li, Cheng; Rawstron, Andrew C.; Shammas, Masood A.; O'Connor, Sheila M.; Fenton, James A. L.; Hideshima, Teru; Chauhan, Dharminder; Tai, Isabella T.; Robinson, Elizabeth (2003-12-15). "Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis". Blood. 102 (13): 4504–4511. doi:10.1182/blood-2003-01-0016. ISSN 0006-4971. PMID 12947006. S2CID 15676924.
  30. ^ Yang, Xiuwei; Claas, Christoph; Kraeft, Stine-Kathrein; Chen, Lan Bo; Wang, Zemin; Kreidberg, Jordan A.; Hemler, Martin E. (2002-02-04). "Palmitoylation of Tetraspanin Proteins: Modulation of CD151 Lateral Interactions, Subcellular Distribution, and Integrin-dependent Cell Morphology". Molecular Biology of the Cell. 13 (3): 767–781. doi:10.1091/mbc.01-05-0275. ISSN 1059-1524. PMC 99597. PMID 11907260.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Chen_Lan-bo&oldid=1258054529"